Global Cancer Diagnostics Market By Technology {ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy} Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) Geography (North America, Europe, APAC, South America, Rest of the World) – Trends and Forecast to 2024 ”,is projected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024. Access Full Report: https://www.databridgemarketresearch.com/reports/global-cancer-diagnostics-market The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Cancer is defined as a malignant growth or tumor resulting from an uncontrolled division of cells. According to Centers for Disease Control and Prevention (CDC), cancer is the second leading cause of mortality, causing approximately 584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR), among others. Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market.
Based on geography the global cancer diagnostics market covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. North America holds the largest market followed by Asia Pacific which is growing rapidly. Brazil and Middle East are among the others geographies growing prolifically. North America dominates the market in terms of consumption of hemostats followed by Europe and APAC.
The global cancer diagnostics market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.The global cancer diagnostics market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market. Some of the major players operating in this market are Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Becton, Dickinson and Company, General Electric Company, QIAGEN N.V., Agilent Technologies, Inc., Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Koninklijke Philips N.V., and C.R. Bard, Inc., Hologic, Inc. among other players. Global Bioburden Testing Market, By Test Type (Aerobic, Anaerobic, Fungi, Spore), By Product Type (Instruments (PCR, Automated Microbial Identification Systems, Microscopes, Others), Consumables (Kits & Strips, Reagents, Others), By Technology (Microbial Filter Method, Advanced Colorimetric Method, Plate Count Method, Rapid Testing), By Application (Raw Material Testing, In-Process Testing, Medical Device Testing, Pharmaceutical & Cosmetic Testing, Food and Beverage Testing), By End-User (Pharmaceutical, Biotechnology, Industrial, Food & Beverages), By Geography (North America, Europe, Asia-Pacific, South America and Middle East Asia) – Industry Trends and Forecast to 2024
Global Cancer Diagnostics Market – Industry Trends and Forecast to 2030
North America Cancer Diagnostics Market – Industry Trends and Forecast to 2028
Europe Cancer Diagnostics Market – Industry Trends and Forecast to 2029
Asia-Pacific Cancer Diagnostics Market – Industry Trends and Forecast to 2029
Global Non-Invasive Cancer Diagnostics Market – Industry Trends and Forecast to 2030
Global Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028
Cancer Diagnostics Market to grow at a CAGR of 6.84% in the forecast period of 2019 to 2026 due to increasing cases of cancer worldwide
Global Cancer Diagnostics Market is Expected to Grow at a CAGR of 11.7% in the Forecast Period 2017-2024
Global Cancer Diagnostics Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026
Europe Cancer Diagnostics Market is Expected to Grow at 5.0% in the Forecast Period of 2020 to 2027
Global Noninvasive Cancer Diagnostics Market is Rising Exponentially at a CAGR of 6.90% in the Forecast Period
Global Prostate Cancer Diagnostics Market is Expected to Grow at 20.1% in the Forecast Period of 2021 to 2028